BeiGene Historical Balance Sheet
BGNE Stock | USD 218.97 6.58 3.10% |
Trend analysis of BeiGene balance sheet accounts such as Short Long Term Debt Total of 976.7 M, Other Current Liabilities of 823.6 M or Total Current Liabilities of 1.9 B provides information on BeiGene's total assets, liabilities, and equity, which is the actual value of BeiGene to its prevalent stockholders. By breaking down trends over time using BeiGene balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining BeiGene latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BeiGene is a good buy for the upcoming year.
BeiGene Inventory |
|
BeiGene |
About BeiGene Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of BeiGene at a specified time, usually calculated after every quarter, six months, or one year. BeiGene Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of BeiGene and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which BeiGene currently owns. An asset can also be divided into two categories, current and non-current.
BeiGene Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of BeiGene assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BeiGene books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on BeiGene balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of BeiGene are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from BeiGene's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.At present, BeiGene's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 1.9 B, whereas Total Stockholder Equity is forecasted to decline to about 2.2 B.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 694.6M | 891.1M | 930.2M | 976.7M | Total Assets | 8.6B | 6.4B | 5.8B | 3.2B |
BeiGene balance sheet Correlations
Click cells to compare fundamentals
BeiGene Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BeiGene balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.6B | 5.6B | 8.6B | 6.4B | 5.8B | 3.2B | |
Short Long Term Debt Total | 277.3M | 562.0M | 694.6M | 891.1M | 930.2M | 976.7M | |
Other Current Liab | 152.7M | 127.8M | 480.0M | 114.3M | 784.4M | 823.6M | |
Total Current Liabilities | 286.0M | 1.1B | 1.6B | 1.0B | 1.8B | 1.9B | |
Total Stockholder Equity | 978.4M | 3.9B | 6.2B | 4.4B | 3.5B | 2.2B | |
Other Liab | 57.1M | 443.3M | 562.5M | 283.7M | 326.3M | 342.6M | |
Net Tangible Assets | 956.3M | 3.9B | 6.2B | 4.3B | 5.0B | 5.2B | |
Property Plant And Equipment Net | 313.1M | 446.3M | 686.7M | 845.9M | 1.4B | 1.5B | |
Net Debt | (340.7M) | (820.0M) | (3.7B) | (3.0B) | (2.3B) | (2.1B) | |
Retained Earnings | (2.0B) | (3.6B) | (5.0B) | (7.1B) | (8.0B) | (7.6B) | |
Accounts Payable | 122.5M | 232.0M | 262.4M | 294.8M | 315.1M | 330.9M | |
Cash | 618.0M | 1.4B | 4.4B | 3.9B | 3.2B | 3.3B | |
Non Current Assets Total | 439.6M | 640.1M | 1.0B | 845.9M | 1.6B | 1.7B | |
Non Currrent Assets Other | 2.5M | 24.6M | 30.7M | (186.5M) | (18.7M) | (17.8M) | |
Other Assets | 108.7M | 186.8M | 8.6B | 819.9M | 2.0 | 1.9 | |
Long Term Debt | 240.7M | 183.6M | 202.1M | 209.1M | 197.6M | 143.1M | |
Cash And Short Term Investments | 985.5M | 4.7B | 6.6B | 4.5B | 3.2B | 2.3B | |
Common Stock Total Equity | 77K | 79K | 118K | 133K | 153.0K | 160.6K | |
Common Stock Shares Outstanding | 60.1M | 83.5M | 92.8M | 103.1M | 104.4M | 72.1M | |
Short Term Investments | 364.7M | 3.3B | 2.2B | 665.3M | 2.6M | 2.5M | |
Liabilities And Stockholders Equity | 1.6B | 5.6B | 8.6B | 6.4B | 5.8B | 3.2B | |
Non Current Liabilities Total | 347.9M | 656.3M | 803.4M | 977.9M | 423.6M | 372.9M | |
Other Current Assets | 85.8M | 133.0M | 246.2M | 190.9M | 205.5M | 215.8M | |
Other Stockholder Equity | 2.9B | 7.4B | 11.2B | 11.5B | 11.6B | 12.2B | |
Total Liab | 633.9M | 1.7B | 2.4B | 2.0B | 2.2B | 2.3B | |
Property Plant And Equipment Gross | 324.9M | 399.5M | 811.0M | 1.1B | 1.6B | 1.7B | |
Total Current Assets | 1.2B | 5.0B | 7.6B | 4.7B | 4.2B | 2.6B | |
Accumulated Other Comprehensive Income | (8.0M) | 6.9M | 18.0M | (77.4M) | (99.4M) | (94.5M) | |
Short Term Debt | 10.8M | 348.9M | 449.5M | 353.0M | 710.3M | 745.8M | |
Common Stock | 79K | 118K | 133K | 135K | 155.3K | 83.2K | |
Property Plant Equipment | 324.9M | 357.7M | 587.6M | 955.9M | 1.1B | 1.2B | |
Deferred Long Term Liab | 11.1M | 10.5M | 10.8M | 14.2M | 16.3M | 10.1M | |
Long Term Debt Total | 189.7M | 240.7M | 183.6M | 202.1M | 232.4M | 156.4M | |
Capital Surpluse | 2.7B | 2.9B | 7.4B | 11.2B | 12.9B | 13.5B | |
Net Receivables | 72.8M | 79.7M | 500.2M | 173.2M | 395.9M | 415.7M | |
Retained Earnings Total Equity | (1.0B) | (2.0B) | (3.6B) | (5.0B) | (4.5B) | (4.2B) | |
Inventory | 28.6M | 89.3M | 242.6M | 282.3M | 416.1M | 436.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
F | Ford Motor | |
CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.95) | Revenue Per Share 29.652 | Quarterly Revenue Growth 0.561 | Return On Assets (0.1) | Return On Equity (0.15) |
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.